Aspect Magnet Technologies & Bruker BioSpin Establish a Collaborative Effort in Developing 1 Tesla Desktop MRI Solutions for ...
September 23 2009 - 8:00AM
Business Wire
At the 2009 World Molecular Imaging Congress (WMIC) in Montreal,
Aspect Magnet Technologies and Bruker BioSpin, a division of Bruker
Corporation (NASDAQ: BRKR), today announced that they have signed a
Memorandum of Understanding (MoU) for the development of a high
performance desktop preclinical MRI system. The new MRI scanner
will benefit from the combination of Aspect’s innovative 1 Tesla
(T) permanent magnet system and Bruker BioSpin’s high-performance
MRI spectrometer technology and its routine preclinical software
package.
The new system is expected to enable scientists to explore new
fields of preclinical MRI research, such as hyperpolarization,
functional applications and contrast agent imaging, all supported
by high-resolution MRI morphology imaging. Both companies will
evaluate the potential new markets and their technological and
applications requirements.
Uri Rapoport, Aspect’s CEO, stated: ”Aspect sees the
collaboration with Bruker BioSpin as a major step forward for
Aspect, and a recognition of Aspect’s breakthrough technology. I’m
sure that there is a very large potential for introducing a 1T
permanent magnet MRI system in the fields of contrast agent usage
and development of hyperpolarization applications. The intended
collaboration between Aspect and Bruker will yield very innovative
and productive solutions.”
Dr. Wulf-Ingo Jung, Managing Director of Bruker BioSpin MRI
GmbH, commented: “High performance desktop MRI systems have the
potential to deliver new research applications to the field of
preclinical and molecular imaging. The planned combined system is
aimed at easy, routine MRI workflow with a compact footprint, low
running costs, no magnetic stray fields outside the magnet, and
remarkable push-button imaging performance, based on the latest
Bruker spectrometer and software technology, in order to enable new
research groups to enter this fascinating field of MRI.”
About Aspect - Aspect Magnet Technologies Ltd. designs,
develops and manufactures innovative, compact-size high-resolution
Magnetic Resonance Imaging (MRI) based systems for the pre-clinical
market performing in-vivo small animal imaging and in-vitro
studies. The company’s innovative MRI system will also provide
medical applications for human extremities such as Carpal Tunnel
Syndrome. Aspect’s breakthrough technology solves many drawbacks in
performance in today's MRI market, such as very high unit cost,
high cost of ownership, complex operation & installation.
Aspect's MRI systems are designed and optimized for the best
performance according to the user's budget & needs. Aspect
vision is to see MRI used routinely, by producing high performance,
high resolution, easy to use and environmentally friendly MRI
systems that are affordable to all.
About Bruker BioSpin
For more information about Bruker BioSpin and Bruker
Corporation, please visit www.bruker-biospin.com and
www.bruker.com.
BRUKER CAUTIONARY STATEMENT
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking statements
as that term is defined in the Private Securities Litigation Reform
Act of 1995. Any forward-looking statements contained herein are
based on current expectations, but are subject to a number of risks
and uncertainties. The factors that could cause actual future
results to differ materially from current expectations include, but
are not limited to, risks and uncertainties relating to adverse
changes in conditions in the global economy and volatility in the
capital markets, the integration of businesses we have acquired or
may acquire in the future, changing technologies, product
development and market acceptance of our products, the cost and
pricing of our products, manufacturing, competition, dependence on
collaborative partners and key suppliers, capital spending and
government funding policies, changes in governmental regulations,
intellectual property rights, litigation, and exposure to foreign
currency fluctuations. These and other factors are identified and
described in more detail in our filings with the SEC, including,
without limitation, our annual report on Form 10-K for the year
ended December 31, 2008, our most recent quarterly reports on Form
10-Q and our current reports on Form 8-K. We disclaim any intent or
obligation to update these forward-looking statements other than as
required by law.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6056580&lang=en
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024